87 related articles for article (PubMed ID: 3491141)
1. Molecular analysis of a functional subtype of HLA-B27. A possible evolutionary pathway for HLA-B27 polymorphism.
Vega MA; Bragado R; Iványi P; Peláez JL; López de Castro JA
J Immunol; 1986 Dec; 137(11):3557-65. PubMed ID: 3491141
[TBL] [Abstract][Full Text] [Related]
2. Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes.
Vega MA; Wallace L; Rojo S; Bragado R; Aparicio P; López de Castro JA
J Immunol; 1985 Nov; 135(5):3323-32. PubMed ID: 3930603
[TBL] [Abstract][Full Text] [Related]
3. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
Calvo V; Rojo S; López D; Galocha B; López de Castro JA
J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.
Vega MA; Ezquerra A; Rojo S; Aparicio P; Bragado R; López de Castro JA
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7394-8. PubMed ID: 2414775
[TBL] [Abstract][Full Text] [Related]
5. HLA-B27 antigenicity: antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes.
Rojo S; López de Castro JA; Aparicio P; Van Seventer G; Bragado R
J Immunol; 1986 Aug; 137(3):904-10. PubMed ID: 2424988
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27.
Rojo S; Aparicio P; Choo SY; Hansen JA; López de Castro JA
J Immunol; 1987 Aug; 139(3):831-6. PubMed ID: 3110285
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.
Hülsmeyer M; Welfle K; Pöhlmann T; Misselwitz R; Alexiev U; Welfle H; Saenger W; Uchanska-Ziegler B; Ziegler A
J Mol Biol; 2005 Mar; 346(5):1367-79. PubMed ID: 15713487
[TBL] [Abstract][Full Text] [Related]
8. HLA-B27 polymorphism in Mumbai, Western India.
Chhaya SU
Tissue Antigens; 2005 Jul; 66(1):48-50. PubMed ID: 15982257
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of an HLA-B27 functional variant, B27d, detected in American blacks.
Rojo S; Aparicio P; Hansen JA; Choo SY; López de Castro JA
J Immunol; 1987 Nov; 139(10):3396-401. PubMed ID: 3500219
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
11. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of an HLA-B7 antigen variant detected by cytotoxic T lymphocytes.
Taketani S; Krangel MS; Spits H; de Vries J; Strominger JL
J Immunol; 1984 Aug; 133(2):816-21. PubMed ID: 6429245
[TBL] [Abstract][Full Text] [Related]
13. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis.
Galocha B; de Castro JA
Arthritis Rheum; 2008 Feb; 58(2):401-12. PubMed ID: 18240209
[TBL] [Abstract][Full Text] [Related]
14. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy.
López D; García-Hoyo R; López de Castro JA
J Immunol; 1994 Jun; 152(11):5557-71. PubMed ID: 8189072
[TBL] [Abstract][Full Text] [Related]
15. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.
Boisgérault F; Tieng V; Stolzenberg MC; Dulphy N; Khalil I; Tamouza R; Charron D; Toubert A
J Clin Invest; 1996 Dec; 98(12):2764-70. PubMed ID: 8981922
[TBL] [Abstract][Full Text] [Related]
16. [Variation in HLA-B27 gene subtypes and susceptibility of ankylosing spondylitis in the Croatian population].
Grubić Z; Kerhin-Brkljacić V; Perić P; Cecuk E; Kastelan A
Reumatizam; 2001; 48(1):7-11. PubMed ID: 12476735
[TBL] [Abstract][Full Text] [Related]
17. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
[TBL] [Abstract][Full Text] [Related]
18. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.
Atagunduz P; Appel H; Kuon W; Wu P; Thiel A; Kloetzel PM; Sieper J
Arthritis Rheum; 2005 Mar; 52(3):892-901. PubMed ID: 15751060
[TBL] [Abstract][Full Text] [Related]
19. HLA-B27: a registry of constitutive peptide ligands.
Lopez de Castro JA; Alvarez I; Marcilla M; Paradela A; Ramos M; Sesma L; Vázquez M
Tissue Antigens; 2004 May; 63(5):424-45. PubMed ID: 15104674
[TBL] [Abstract][Full Text] [Related]
20. Conventional alloantisera can recognize the same HLA-B27 polymorphism as detected by cytotoxic T lymphocytes.
de Waal LP; Krom FE; Breur-Vriesendorp BS; Engelfriet CP; Lopez de Castro JA; Ivanyi P
Hum Immunol; 1987 Dec; 20(4):265-71. PubMed ID: 2449411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
